Explore Tools Publish ReviewPeer Review CV+

/The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease

Articles (10)

About Privacy Terms

Copyright © 2026. AllSci Corp. All rights reserved.